Principal investigator of the Cell cycle and Cancer Laboratory - Biomedical Research Group in Urology at the Vall d'Hebron Research Institute (VHIR), thanks to Miguel Servet Program, since February 2014. Becoming Miguel Servet II Principal Investigator (after recently obtaining the maximum qualification by the Instituto Carlos III) and Head of the Group in Biomedical Research in Urology in January 2019. PhD in Biology from the University of Barcelona and the CSIC and degree in biology (genetics and biotechnology) by the University of Barcelona. I completed my doctoral thesis in the prostate cancer field and moved for my post-doctoral stay to the Max Plank Institute of Biochemistry in Munich (Germany) where I was trained and acquired experience in the principles of cell division and mechanisms of cell cycle control in human cells (mitotic control by mitotic kinases and aneuployd and faithful segregation of chromosomes and high-resolution Mass spectrometry-based proteomics approaches). Subsequently, I moved to the Biozentrum, University of Basel (Switzerland) as Project Leader until 2014, where I engaged in the supervision of my own PhD students, master students, becoming Principal Investigator of my projects in national and international calls.

Currently, the efforts of my team are devoted to try to give answer to de main challanges in the field of cancer, in particular we focus our attention to hormone-dependent tumours, namely ovarian tumors in women and prostate tumors in men. We aim at giving answer to current needs for early diagnosis (mainly in ovarian cancer) and the need for new therapeutic approaches (in both type of tumors, specifically those of agressive behavior appearing in advances stages). We also dedicate efforts to understand the progression of tumors from the molecular point of view, trying to identify new therapeutic targets, focusing mainly on studying cell-division dependent vulnerabilities. Our group is formed by 7 members including myself, a senior postdoctoral researcher and 5 PhD students at different stages of their PhD thesis. In the last year I have been able to set up the laboratory, obtaining important competitive funding to carry out our research. Stable and formal agreements with differents pharmaceutical companies have been also achieved in order to test novel promising therapeutics venues based on our research. I am official teacher of our Master at VHIR. Finally, I contribute to important tasks in our institution by being currently member of the Internal Scientific Committee as well as the head of Evaluation Commission for fellowships and grants.